Avet Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AVET
AVET has forty-one approved drugs.
Summary for Avet
| US Patents: | 0 |
| Tradenames: | 36 |
| Ingredients: | 35 |
| NDAs: | 41 |
Drugs and US Patents for Avet
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avet Lifesciences | METOCLOPRAMIDE | metoclopramide hydrochloride | INJECTABLE;INJECTION | 204756-001 | Dec 20, 2013 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Avet Lifesciences | MELPHALAN HYDROCHLORIDE | melphalan hydrochloride | INJECTABLE;INJECTION | 206523-001 | Oct 29, 2024 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Avet | ACHROMYCIN V | tetracycline hydrochloride | CAPSULE;ORAL | 050278-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
